ARTICLE | Management Tracks
“His counsel and legacy will always remain with us,” says Pappas team
By Paul Bonanos, Director of Biopharma Intelligence
October 29, 2024 11:12 PM UTC
Pappas Ventures announced the passing of Senior Venture Partner Ernest Mario, a longtime biopharma executive who led and invested in biopharmas across several decades. He was 86.
Mario may have been best known for guiding delivery company Alza Corp. through its $12.3 billion acquisition by Johnson & Johnson (NYSE:JNJ) in 2001, a deal that was among the largest in pharma history when it took place. Before joining Alza in 1993, he had been CEO of Glaxo plc, now GSK plc (LSE:GSK; NYSE:GSK), for nearly four years…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654016/ernest-mario-pappas-partner-who-steered-alza-into-j-j-deal-passes-away